Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 Second Quarter Earnings

NEW YORK--(Business Wire)--
Forest Laboratories, Inc. (NYSE: FRX), an international manufacturer and
marketer of pharmaceutical products, will release its Fiscal 2010 Second Quarter
financial results before the U.S. stock market opens on Tuesday, October 20,
2009. Later that day, at 10:00 AM EDT, Forest will host a conference call where
Dr. Lawrence Olanoff, President and Chief Operating Officer and Frank Perier,
Senior Vice President-Finance and Chief Financial Officer, will discuss the
financial results and relevant company and industry topics. The conference call
will be webcast live beginning at 10:00 AM ET on the Company's website
www.frx.com and also on the website www.streetevents.com. Please log on to
either website at least fifteen minutes prior to the conference call as it may
be necessary to download software to access the call. A replay of the conference
call will be available until November 4, 2009 at both websites and also by
dialing 1-800-642-1687 (US investors) or +1-706-645-9291 (international
investors), Conference Call ID 32976879.

About Forest Laboratories

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a
long track record of building partnerships and developing and marketing products
that make a positive difference in people`s lives. In addition to its
well-established franchises in therapeutic areas of the central nervous and
cardiovascular systems, Forest`s current pipeline includes product candidates in
all stages of development and across a wide range of therapeutic areas. The
company is headquartered in New York, NY. To learn more about Forest
Laboratories, visit www.frx.com.

Except for the historical information contained herein, this release contains
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements involve a number of risks and
uncertainties, including the difficulty of predicting FDA approvals, the
acceptance and demand for new pharmaceutical products, the impact of competitive
products and pricing, the timely development and launch of new products, and the
risk factors listed from time to time in Forest Laboratories` Annual Report on
Form 10-K, Quarterly Report on Form 10-Q, and any subsequent SEC filings.

Forest Laboratories, Inc.
Frank J. Murdolo, 1-212-224-6714
Vice President - Investor Relations
frank.murdolo@frx.com

Copyright Business Wire 2009